Discovery & Development

A Korean team have conducted a study on a peptide that could help to produce medicines capable of crossing cell membranes and interfering with PPIs.

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

Work at the Max Planck Institute of Molecular Physiology has revealed a welcome surprise: a potential new class of COVID-19 drugs.

A pill developed at MIT and inspired by tortoises could replace injections for monoclonal antibody therapies.

Emerging technologies are proving that small molecules aren't yesterday's news.

Meet the international coalition working to tackle COVID-19 in low- and middle-income countries.

How a drug approval changed the lives of patients living with rare disease.

An institute for the gifted with X in its name, presided over by a wise doctor, has launched two new projects. Somebody call Magneto!

Pfizer-BioNTech COVID-19 vaccine receives full FDA approval.

A diverse range of malaria treatments will make all the difference in the prevention of resistance.